Individuals suffering from chronic headache or pain are, among chronic sufferers, the most sensitive to develop health damage due to overuse or abuse of analgesics or other pain-controlling drugs. Pharmacovigilance is a term that describes the activities of control and surveillance on adverse events to drugs. Three different branches are devoted to that activity: post-market surveillance, investigation of product complaints, and monitoring of adverse reactions. Any product registered in each country is continously under control of the local authority to comply with the pre-registration standards of quality, efficacy and safety. Patients suffering from headache disorders or other pain syndromes are subject to long-term treatment with various substances for the control of pain or of headache or for the prophylaxis of that disabling clinical conditions. Thus, this category of patients is highly exposed to drug-related side effects. Various organizations run Web sites to control over time the safety of drugs, with the purpose to monitor trends in reported suspected adverse reactions. Reports received by each organization are prioritized in terms of severity or likely casuality, and are analyzed with any previous similar reports on the same product. The management of the information on critical safety issue risk implements then additional safety studies to optimize the benefit-risk balance of those compounds.
Adverse drug reactions (ADR) monitoring is carried out through spontaneous reporting of adverse reactions incidentally encountered by doctors, pharmacists and dentists unfortunately still on a voluntary basis. These health professionals should be encouraged to report all suspected ADR irrespective of their seriousness, unsureness of casualty or relative rarity. On that basis, local authorities may decide for labelling changes, insertion of warnings, additions of precautionary statements, de-registration, suspension of registration, or batch recall for the suspected substances.
The Web is an important information channel for disseminating that information on ADR through scientific journals, pharmacovigilance bulletins and national or international agencies of health safety, and for stimulating the use of guidelines and procedures on reporting ADR.
Many countries present information on pharmacovigilance activities on public health ministry, agency or inspectorate Web sites, several of them still in national language only.
The following Web sites dedicated to pharmacovigilance have been selected for the feasibility to obtain information on pharmacovigilance or to submit reports on that argument. 
